The risk for both self-reported and symptomatic flare in inflammatory bowel disease is associated with psychosocial factors, ...
For both induction and maintenance therapy, subcutaneous guselkumab significantly improves clinical outcomes in patients with ...
The traditional understanding of inflammation focused primarily on its acute manifestations, the classic signs of redness, ...
Reported positive interim pharmacokinetic ("PK") and safety data in Phase 1 trial of SPY001 in November 2024 and strengthened the balance sheet with a $230 million ...
In a US study, researchers found that 35% of adults with IBD screened positive for spondyloarthritis, despite having no known SpA diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback